Pathogenic therapy of acne patients-Reference-Cited by-同舟云学术

Pathogenic therapy of acne patients

Published:2012-12-15 Issue:6 Volume:88 Page:82-89
ISSN:2313-6294
Container-title:Vestnik dermatologii i venerologii
language:
Short-container-title:Vestnik dermatologii i venerologii

Author:

VOLKOVA YE N,GRIGORIYEVA A A,YELISTRATOVA I V

Abstract

The authors provide a detailed description of the composition, pharmacokinetic and pharmacodynamic properties of Acnecutan, an innovation drug for the system pathogenic therapy of acne. They present the results of clinical observations and treatment of 88 patients suffering from moderate to severe acne forms with Acnecutan.

Publisher

Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov

Reference12 articles.

1. Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49: 1—37.

2. Plewig G., Kligman A. Acne & rosacea. 3rd ed., Berlin: Springer 2002.

3. Zouboulis C.C., Eady A., Philpott M. et al. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143—152.

4. Kuwahara K., Kitazawa T., Kitagaki H. et al. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005; 38: 47—55.

5. Leyden J.J. Therapy for acne vulgaris. N Engl J Med 1997; 336: 1156—1162.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trouble issues of acne therapy with systemic isotretinoin;Russian Journal of Clinical Dermatology and Venereology;2024

2. Acne from the point of view of dermatologists and cosmetologists;Vestnik dermatologii i venerologii;2014-08-24